“The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber’s remarkable leadership,” said ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

CEOs emphasize the need to stay nimble and rethink supply chains as barriers to trade are erected in an increasingly ...

Although the timing of tariffs is uncertain, we believe that it is likely that Trump will not want to wait two to three years ...

Takeda has been restructured under new CEO Christophe Weber, who took over in 2014 and has focused the company on cancer and specialist gastrointestinal drugs, and early stage central nervous ...

The Japanese pharma company acquired Ariad a year ago for $5.2bn, and the latest, more modest acquisition, shows that Takeda's chief Christophe Weber sees buy-outs as ongoing route to growth.

Takeda’s CEO Christophe Weber got the deal across the line despite protests from a small but vocal group of shareholders concerned about repaying the bank loan of more than $30 billion needed to ...

Another example of the trend in a country where countless numbers of Japanese study English even after their school days are long over concerns Takeda ... which appointed Christophe Weber from ...